Looks like I'm not the only one on spring break this week…
My StocksToTrade scans are light and most premarket runners are trading low-volume.
But we are still able to pick out some of the best plays in penny stocks.
Like 50%+ runner Pyxis Oncology, Inc. (NASDAQ: PYXS) yesterday...
It was the second day of the stock's run. And Oracle picked it out as one of the top stocks with explosive potential…
But Oracle and I disagreed on our ideal entries.
Who do you think had the better entry? And which one would you have taken?
It all depends on your trading style — check out both entries to see which one you like and get to know yourself better as a trader…
Oracle's Entry Vs. My Entry
Oracle had Pyxis Oncology, Inc. (NASDAQ: PYXS) on its watchlist yesterday morning with a signal entry of $3.10.
Our algorithm identified it as a potentially volatile play yesterday because it was gapping up after having a big gap up and going from $2.21 to $3.49 on Monday.
But on Monday the price action was choppy…
It spiked huge right at the open, then just went sideways. It had a little perk midday. But mostly it was just sideways price action…
That's why my entry for PYXS was a little more conservative.
In my morning live webinar, I gave a potential entry of $3.50. I figured there were probably a ton of day-one bagholders who chased the spike at the open on Monday.
So I thought we'd see some selling at the market open yesterday.
Oracle gave a signal entry price that would've gotten you in the stock early. But once it was through $3.10 it chopped sideways for a while … It even dipped below VWAP briefly before going higher.
If you're a patient trader, this play definitely could've worked for you. And you could've taken profits at Oracle resistance levels all the way up…
If you waited for my entry, you would've had to be quick to get in. Because once it blew through $3.50 it spiked right to the $3.75 area before consolidating.
It held Oracle's lower support level and broke through the next resistance level at $3.88, and topped out at $4.19.
Using Oracle and my 15 years of experience gives you trade ideas that are identified by an algorithm, but that is also deciphered with human reason and experience...
And you get to decide whether you like to be aggressive with Oracle's entry, or if you're conservative and preferred my entry…
(As an Amazon Associate, we earn from qualifying purchases.)
13809 Research Boulevard, Suite 500, Austin, TX 78750
*Please note that these kinds of trading results are not typical. Most traders lose money. It takes years of dedication, hard work, and discipline to learn how to trade, and individual results will vary. Trading is inherently risky. Before making any trades, remember to do your due diligence and never risk more than you can afford to lose.
This is for informational purposes only as StocksToTrade is not registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund.
StocksToTrade cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing.
StocksToTrade in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, StocksToTrade accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.
Tidak ada komentar:
Posting Komentar